Randal Chase

Biography

Dr. Pursue has over 40 years of involvement in biotechnology and related fields. Randal started his vocation at Bristol Meyers and Glaxo Canada Inc., where he held the places of Director and Senior Vice President, individually. He is a previous President of a few organizations, including Quadra Logic Technologies, Inc., North American Vaccine and Aventis Pasteur Canada. Too, Dr. Pursue has filled in as President and Chief Executive Officer of ImmunoVaccine Technologies Inc. from 2006 to 2011. From 2005 to 2006, he was Chairman of the Board of Directors of Molecular Templates Inc. From 2001 to 2004, Dr. Pursue was President of Shire Biologics Inc and from May 2001 to August 2002, he filled in as Senior Vice-President, Vaccines Operations of Biochem Pharma Inc. Among his various arrangements, Dr. Pursue has been an individual from the leading group of Biotech Canada, and has filled in as a Director of Bioject Medical Technologies, Inc. (NASDAQ), Acambis PLC (London Stock Exchange, NASDAQ), and of Conjuchem Inc. also, of Conjuchem Biotechnologies Inc. (TSX). Most as of late, Dr. Pursue was Chairman of the Board and Director of Medicago. He as of now fills in as Chairman of MediMabs, a secretly held organization, and is an individual from the Board of Geovax Labs, Inc., an antibody organization exchanging on the OTCQX.  

Research Interest

Targeted therapeutics to treat cancer